Atlas Trials

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Clinical trial NCT02002611 · COMPLETED

Trial details

NCT number
NCT02002611
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2013-12-01
Primary completion
2014-02-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.